178 related articles for article (PubMed ID: 32239274)
21. Poorly Differentiated and Undifferentiated Thyroid Carcinomas.
Eloy C; Ferreira L; Salgado C; Soares P; Sobrinho-Simões M
Turk Patoloji Derg; 2015; 31 Suppl 1():48-59. PubMed ID: 26177317
[TBL] [Abstract][Full Text] [Related]
22. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
24. Pleomorphic giant cell carcinoma of the esophagus with coexpression of cytokeratin and vimentin and neuroendocrine differentiation.
Mosnier JF; Balique JG
Arch Pathol Lab Med; 2000 Jan; 124(1):135-8. PubMed ID: 10629146
[TBL] [Abstract][Full Text] [Related]
25. The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma) - own observations.
Walczyk A; Kowalska A; Sygut J
Endokrynol Pol; 2010; 61(5):467-73. PubMed ID: 21049460
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
[No Abstract] [Full Text] [Related]
27. Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.
Sykorova V; Dvorakova S; Vcelak J; Vaclavikova E; Halkova T; Kodetova D; Lastuvka P; Betka J; Vlcek P; Reboun M; Katra R; Bendlova B
Anticancer Res; 2015 Apr; 35(4):2029-36. PubMed ID: 25862857
[TBL] [Abstract][Full Text] [Related]
28. [Anaplastic thyroid carcinoma with osteoclast-like giant cells].
Serezhin BS; Anichkov NM; Avdeenko IuL
Arkh Patol; 1997; 59(6):50-3. PubMed ID: 9483219
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
[TBL] [Abstract][Full Text] [Related]
31. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic thyroid carcinoma: morphologic findings and PAX-8 expression in cytology specimens.
Rivera M; Sang C; Gerhard R; Ghossein R; Lin O
Acta Cytol; 2010; 54(5):668-72. PubMed ID: 20968153
[TBL] [Abstract][Full Text] [Related]
33. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.
Bishop JA; Sharma R; Westra WH
Hum Pathol; 2011 Dec; 42(12):1873-7. PubMed ID: 21663937
[TBL] [Abstract][Full Text] [Related]
34. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
[TBL] [Abstract][Full Text] [Related]
36. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
Albores-Saavedra J; Hernandez M; Sanchez-Sosa S; Simpson K; Angeles A; Henson DE
Am J Surg Pathol; 2007 May; 31(5):729-36. PubMed ID: 17460457
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors of outcome in poorly differentiated thyroid carcinomas.
de la Fouchardière C; Decaussin-Petrucci M; Berthiller J; Descotes F; Lopez J; Lifante JC; Peix JL; Giraudet AL; Delahaye A; Masson S; Bournaud-Salinas C; Borson Chazot F
Eur J Cancer; 2018 Mar; 92():40-47. PubMed ID: 29413688
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic giant cell carcinoma of the urinary bladder.
Lopez-Beltran A; Blanca A; Montironi R; Cheng L; Regueiro JC
Hum Pathol; 2009 Oct; 40(10):1461-6. PubMed ID: 19467692
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of locally advanced anaplastic thyroid carcinoma by chemotherapy and hyperfractionated radiotherapy.
Shinohara S; Kikuchi M; Naito Y; Fujiwara K; Hori S; Tona Y; Yamazaki H; Kobayashi H; Ishihara T
Auris Nasus Larynx; 2009 Dec; 36(6):729-32. PubMed ID: 19269756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
